These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17060974)

  • 1. HIV evolution and escape.
    Richman DD; Little SJ; Smith DM; Wrin T; Petropoulos C; Wong JK
    Trans Am Clin Climatol Assoc; 2004; 115():289-303. PubMed ID: 17060974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV. Escape artist par excellence.
    Cohen J
    Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245
    [No Abstract]   [Full Text] [Related]  

  • 3. Conflicting Selection Pressures Will Constrain Viral Escape from Interfering Particles: Principles for Designing Resistance-Proof Antivirals.
    Rast LI; Rouzine IM; Rozhnova G; Bishop L; Weinberger AD; Weinberger LS
    PLoS Comput Biol; 2016 May; 12(5):e1004799. PubMed ID: 27152856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution and Diversity of HIV-1].
    Metzner KJ
    Praxis (Bern 1994); 2011 Jan; 100(1):29-35. PubMed ID: 21210358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-resistance evolution requires new strategies. Mutation risk higher if HIV RNA increases.
    AIDS Alert; 2005 Jan; 20(1):3. PubMed ID: 15717352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMC 125 possibly effective against NNRTI-resistant HIV.
    IAPAC Mon; 2004 Jan; 10(1):9. PubMed ID: 15108674
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation and control of the human immunodeficiency virus.
    Stengel RF
    Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV evolution in response to HLA-restricted CTL selection pressures: a population-based perspective.
    Carlson JM; Brumme ZL
    Microbes Infect; 2008 Apr; 10(5):455-61. PubMed ID: 18407775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombination in HIV and the evolution of drug resistance: for better or for worse?
    Bretscher MT; Althaus CL; Müller V; Bonhoeffer S
    Bioessays; 2004 Feb; 26(2):180-8. PubMed ID: 14745836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grim news for vaccine.
    AIDS Patient Care STDS; 2002 Oct; 16(10):513-4. PubMed ID: 12442739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Selection and use of tests for detecting HIV resistance].
    Eiros JM; Hernández B; Labayru C; de Lejarazu RO
    Rev Esp Quimioter; 2001 Sep; 14(3):242-53. PubMed ID: 11753445
    [No Abstract]   [Full Text] [Related]  

  • 14. Averting the evolution of drug resistance.
    Kieffer T; Siliciano R
    Hopkins HIV Rep; 2004 Jul; 16(4):9-10. PubMed ID: 15386837
    [No Abstract]   [Full Text] [Related]  

  • 15. Cornering HIV: taking advantage of interactions between selective pressures.
    Avila-Ríos S; Reyes-Terán G; Espinosa E
    Med Hypotheses; 2007; 69(2):422-31. PubMed ID: 17280799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic mice.
    Okazaki T; Terabe M; Catanzaro AT; Pendleton CD; Yarchoan R; Berzofsky JA
    J Virol; 2006 Nov; 80(21):10645-51. PubMed ID: 16920824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV immunology better understood and vaccination attempts started.
    Wahren B; Landay A
    AIDS; 2002; 16 Suppl 4():S85-8. PubMed ID: 12699004
    [No Abstract]   [Full Text] [Related]  

  • 18. Intra-host evolution of human immunodeficiency virus type 1 and viral fitness.
    Clementi M; Canducci F; Bagnarelli P; Menzo S
    New Microbiol; 2004 Apr; 27(2 Suppl 1):41-4. PubMed ID: 15646063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor].
    Delaugerre C
    Med Mal Infect; 2010 Sep; 40 Suppl 1():S1-10. PubMed ID: 20800182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INFECTIOUS DISEASE. Researchers claim to find HIV sanctuaries.
    Cohen J
    Science; 2016 Jan; 351(6272):434. PubMed ID: 26823407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.